Identification of a novel marker associated with risk for delayed chemotherapy-induced vomiting

@article{Higa2012IdentificationOA,
  title={Identification of a novel marker associated with risk for delayed chemotherapy-induced vomiting},
  author={Gerald M. Higa and Miklos L. Auber and Gerry Hobbs},
  journal={Supportive Care in Cancer},
  year={2012},
  volume={20},
  pages={2803-2809}
}
Besides chemotherapy drugs, a number of patient-related factors (i.e., gender, age, history of alcohol consumption, and/or motion sickness) may be used to calculate the risk for chemotherapy-induced vomiting. We evaluated data with the intent of identifying a unique variable associated with delayed vomiting in patients receiving moderately emetogenic chemotherapy (MEC). From an ongoing research study, the serotonin metabolite, 5-hydroxyindole acetic acid (5-HIAA), creatinine, and substance P… CONTINUE READING